References
Tachibana M, Miyakawa A, Tazaki H, Nakamura K, Kubo A, Hata J, Nishi T, Amano Y (1995) Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte-colony stimulating factor. Cancer Res 55:3438–3443
Kyo S, Kanaya T, Takakura M, Inoue M (2000) A case of cervical cancer with aggressive tumor growth: possible autocrine growth stimulation by G-CSF and Il-6. Gynecol Oncol 78:383–387
Savarese TM, Mitchell K, McQuain C, Campbell CL, Guardiani R, Wuu J, Ollari C, Reale F, Nelson BE, Chen A, Quesenberry PJ (2001) Coexpression of granulocyte colony stimulating factor and its receptor in primary ovarian carcinomas. Cancer Lett 162:105–115
Connor JP (2006) Aggressive carcinosarcoma of the uterine cervix associated with high levels of granulocyte colony stimulating factor: case report and laboratory correlates. Gynecol Oncol 103:349–353
Usuda H, Naito M, Ohyach K, Iizumi T (1997) A case of multiple myeloma producing granulocyte colony-stimulating factor. Pathol Int 47:866–869
Kohmura K, Miyakawa Y, Kameyama K, Kizaki M, Ikeda Y (2004) Granulocyte colony stimulating factor-producing multiple myeloma associated with neutrophilia. Leuk Lymphoma 45:1475–1479
Kusaba N, Yoshida H, Ohkubo F, Mishima K, Shimamastu K, Okamura T, Sata M (2004) Granulocyte-colony stimulating factor-producing myeloma with clinical manifestations mimicking chronic neutrophilic leukemia. Rinsho Ketsueki 45:228–232 (in Japanese)
Nagai M, Oda S, Iwamoto M, Marumoto K, Fujita M, Takahara J (1996) Granulocyte-colony stimulating factor concentrations in a patient with plasma cell dyscrasia and clinical features of chronic neutrophilic leukaemia. J Clin Pathol 49:858–860
de la Rubia J, Bonanad S, Palau J, Sanz GF, Sanz MA (1994) Rapid progression of multiple myeloma following G-CSF mobilization. Bone Marrow Transplant 14:475–476
Meropol NJ, Miller LL, Korn EL, Braitman LE, MacDermott ML, Schuchter LM (1992) Severe myelosuppression resulting from concurrent administration of granulocyte colony-stimulating factor and cytotoxic chemotherapy. J Natl Cancer Inst 84:1201–1203
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
TM received personal fees from Janssen Pharma, Takeda Pharmaceutical, and Kyowa Kirin. The remaining authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from the patient included in the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kikuchi, T., Kato, J., Koda, Y. et al. Safe administration of granulocyte colony-stimulating factor (G-CSF) to a patient with G-CSF–producing multiple myeloma. Ann Hematol 99, 1667–1668 (2020). https://doi.org/10.1007/s00277-020-04120-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-020-04120-4